Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitorsAmin H. Nassar, Alexander Gusev, Adam J. Schoenfeld et al.|Cancer Cell|2022Cited by 117